Advanta VXT Vascular Graft, Flixene Vascular Graft— 510(k) K231972
Substantially EquivalentAtrium Medical Corporation
FDA 510(k) clearance K231972 for Advanta VXT Vascular Graft, Flixene Vascular Graft, Substantially Equivalent on 2024-03-28. Applicant: Atrium Medical Corporation. Device class: 2.
Clearance details
- Applicant
- Atrium Medical Corporation
- Product code
- Code DSY
- Device class
- Class 2
- Regulation
- 21 CFR 870.3450
- Advisory panel
- Cardiovascular
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Merrimack, NH, US
Recent devices under product code DSY
view allMore clearances from Atrium Medical Corporation
view all- K201305 — Auto transfusion (ATS) Chest Drains: Ocean Water Seal Chest Drain, Oasis Dry Suction Water Seal Chest Drain, Express Dry Seal Chest Drain
- K151386 — C-QUR, C-QUR FX, C-QUR TacShield, C-QUR V-Patch, C-QUR CentriFX, C-QUR Mosaic
- K151437 — ProLite Mesh, ProLite Ultra Mesh, ProLoop Mesh Plug
- K130142 — FLIXENE IFG VASCULAR GRAFT
- K110110 — ATRIUM CENTRILFX MESH
Adverse events under product code DSY
product code DSY- Death
- 29
- Injury
- 694
- Total
- 723
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.